Drug Manufacturers - Specialty & Generic · Healthcare
Chairman, Board Member
2020-05-05–present
Chairman
Amneal Pharmaceuticals, Inc. (AMRX)Board Member
Amneal Pharmaceuticals, Inc. (AMRX)Equibles does not estimate personal net worth.
Get an email with a short summary when Amneal Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AMRX alertsPaul Meister is recorded as Board Member at Amneal Pharmaceuticals, Inc. (AMRX) since May 5, 2020 and Chairman at Amneal Pharmaceuticals, Inc. (AMRX). The newest filing on record that lists Paul Meister as Chairman at Amneal Pharmaceuticals, Inc. (AMRX) is dated March 25, 2026. Quanterix Corp reported in an 8-K filed November 20, 2025 that Paul Meister retired as Board of Directors, effective November 20, 2025. Amneal Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amneal Pharmaceuticals, Inc. includes Chintu Patel (CEO and Board Member), Chirag Patel (CEO and Board Member), Anastasios (Tasos) G. Konidaris (CFO) and 7 others.
“On November 20, 2025, Paul Meister and David Walt, Ph.D. notified Quanterix Corporation (the "Company") of their retirement from the Board of Directors of the Company (the "Board") and each committee of the Board on which they served, effective immediately.”
2020-05-05–present
Start not stated–present
Last confirmed March 25, 2026
Drug Manufacturers - Specialty & Generic · Healthcare
Chairman, Board Member
2020-05-05–present